Unknown

Dataset Information

0

MicroRNA 329 suppresses angiogenesis by targeting CD146.


ABSTRACT: CD146, an endothelial biomarker, has been shown to be aberrantly upregulated during pathological angiogenesis and functions as a coreceptor for vascular endothelial growth factor receptor 2 (VEGFR-2) to promote disease progression. However, the regulatory mechanisms of CD146 expression during angiogenesis remain unclear. Using a microRNA screening approach, we identified a novel negative regulator of angiogenesis, microRNA 329 (miR-329), that directly targeted CD146 and inhibited CD146-mediated angiogenesis in vitro and in vivo. Endogenous miR-329 expression was downregulated by VEGF and tumor necrosis factor alpha (TNF-?), resulting in the elevation of CD146 in endothelial cells. Upregulation of CD146 facilitated an endothelial response to VEGF-induced SRC kinase family (SKF)/p38 mitogen-activated protein kinase (MAPK)/NF-?B activation and consequently promoted endothelial cell migration and tube formation. Our animal experiments showed that treatment with miR-329 repressed excessive CD146 expression on blood vessels and significantly attenuated neovascularization in a mouse model of pathological angiogenesis. Our findings provide the first evidence that CD146 expression in angiogenesis is regulated by miR-329 and suggest that miR-329 could present a potential therapeutic tool for the treatment of angiogenic diseases.

SUBMITTER: Wang P 

PROVIDER: S-EPMC3753872 | biostudies-other | 2013 Sep

REPOSITORIES: biostudies-other

altmetric image

Publications

MicroRNA 329 suppresses angiogenesis by targeting CD146.

Wang Ping P   Luo Yongting Y   Duan Hongxia H   Xing Shu S   Zhang Jianlin J   Lu Di D   Feng Jing J   Yang Dongling D   Song Lina L   Yan Xiyun X  

Molecular and cellular biology 20130722 18


CD146, an endothelial biomarker, has been shown to be aberrantly upregulated during pathological angiogenesis and functions as a coreceptor for vascular endothelial growth factor receptor 2 (VEGFR-2) to promote disease progression. However, the regulatory mechanisms of CD146 expression during angiogenesis remain unclear. Using a microRNA screening approach, we identified a novel negative regulator of angiogenesis, microRNA 329 (miR-329), that directly targeted CD146 and inhibited CD146-mediated  ...[more]

Similar Datasets

| S-EPMC4035535 | biostudies-literature
| S-EPMC5652965 | biostudies-literature
| S-EPMC4811144 | biostudies-other
| S-EPMC6667842 | biostudies-other
| S-EPMC5264134 | biostudies-literature
| S-EPMC10157725 | biostudies-literature
| S-EPMC6993250 | biostudies-literature
| S-EPMC5593553 | biostudies-literature
| S-EPMC1482591 | biostudies-literature
| S-EPMC5494889 | biostudies-other